Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity (Q39754750)

14 September 2017

Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity (English)

1 reference

14 September 2017

endometrial carcinoma

1 reference

3

1 reference

14 September 2017

Feng-qiang Wang

1

1 reference

14 September 2017

Edgardo V Ariztia

2

1 reference

14 September 2017

Faith R Horton

4

1 reference

14 September 2017

Yoel Smicun

5

1 reference

14 September 2017

Jessica A Hetherington

6

1 reference

14 September 2017

Phillip J Smith

7

1 reference

14 September 2017

David A Fishman

8

1 reference

14 September 2017

language of work or name

English

0 references

publication date

6 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

117

1 reference

14 September 2017

1

1 reference

14 September 2017

88-95

1 reference

14 September 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Stage I endometrial adenocarcinoma: treatment results in 835 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Dissemination and growth of cancer cells in metastatic sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lipid characteristics in metastatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

The tumor microenvironment: key to early detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

The emerging role of lysophosphatidic acid in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

S1P regulation of ovarian carcinoma invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Abnormal serum lysophospholipids in multiple myeloma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

The significance of plasma lysophospholipids in patients with renal failure on hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

LPA receptor 2 mediates LPA-induced endometrial cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophospholipid interactions with protein targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid induces clonal generation of mouse neurospheres via proliferation of Sca-1- and AC133-positive neural progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid possesses dual action in cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Structure and function of matrix metalloproteinases and TIMPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Matrix metalloproteinases as therapeutic targets in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

MT1-MMP and MMP-7 in invasion and metastasis of human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2009.12.012

1 reference

14 September 2017

1 reference